161 related articles for article (PubMed ID: 16807224)
1. The problem of exogenous subclinical hyperthyroidism.
Batrinos ML
Hormones (Athens); 2006; 5(2):119-25. PubMed ID: 16807224
[TBL] [Abstract][Full Text] [Related]
2. Are thyroid function tests too frequently and inappropriately requested?
Roti E; Gardini E; Magotti MG; Pilla S; Minelli R; Salvi M; Monica C; Maestri D; Cencetti S; Braverman LE
J Endocrinol Invest; 1999 Mar; 22(3):184-90. PubMed ID: 10219885
[TBL] [Abstract][Full Text] [Related]
3. [Is there a need for treatment in subclinical hypo- and hyperthyroidism?].
Lerch M; Meier C; Staub JJ
Ther Umsch; 1999 Jul; 56(7):369-73. PubMed ID: 10434773
[TBL] [Abstract][Full Text] [Related]
4. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
Sorger D; Schenk S; Schneider G
Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
[TBL] [Abstract][Full Text] [Related]
5. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
[TBL] [Abstract][Full Text] [Related]
7. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function].
Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L
Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349
[TBL] [Abstract][Full Text] [Related]
8. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
[TBL] [Abstract][Full Text] [Related]
9. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
10. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
[TBL] [Abstract][Full Text] [Related]
13. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
14. [Free thyroxine estimation for screening of hyper- and hypothyroidism in an adult population].
Fukazawa H; Sakurada T; Yoshida K; Kitaoka H; Nomura T; Suzuki M; Kaise N; Kaise K; Yamamoto M; Saito S
Nihon Naibunpi Gakkai Zasshi; 1984 Feb; 60(2):91-100. PubMed ID: 6724056
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
[TBL] [Abstract][Full Text] [Related]
16. An update on subclinical hypothyroidism and subclinical hyperthyroidism.
Fatourechi MM; Fatourechi V
Expert Rev Endocrinol Metab; 2014 Mar; 9(2):137-151. PubMed ID: 30743756
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
[TBL] [Abstract][Full Text] [Related]
18. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Denereaz N; Lemarchand-Beraud T
Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
[TBL] [Abstract][Full Text] [Related]
19. [Autonomy of the thyroid gland: is there an "organ hyperthyroidism" of "euthyroid" patients?].
Wawrzyn H; Hesch RD
Med Klin (Munich); 2000 Aug; 95(8):421-8. PubMed ID: 10985062
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
Faber J; Wiinberg N; Schifter S; Mehlsen J
Eur J Endocrinol; 2001 Oct; 145(4):391-6. PubMed ID: 11580994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]